|
|
Gene Symbol |
MIR223 |
|
Aliases |
MIRN223, miRNA223, mir-223 |
|
Entrez Gene ID |
|
|
Gene Name |
MicroRNA 223 |
|
Chromosomal Location |
Xq12 |
|
HGNC ID |
|
|
Summary |
microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009]
|
|
|
|
Associated Diseases
Disease group | Disease Name | References |
Blood Disorders |
Hematopoietic Disease |
|
Blood Coagulation Disorders |
|
Myelodysplastic Syndrome |
|
Kawasaki disease |
|
Cardiovascular Diseases |
Acute Coronary Syndrome |
|
Coronary heart disease |
|
Pulmonary Hypertension |
|
Cardiovascular Abnormalities |
|
Atherosclerosis |
|
Myocardial Infarction |
|
Aortic valve calcification |
|
Cardiomyopathy |
|
Atrial Fibrillation |
|
Aortic Aneurysm |
|
Heart Failure |
|
Hypertensive disease |
|
Rheumatic Carditis |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Hemorrhages |
|
Infection of amniotic cavity |
|
Thalassemia |
|
Digestive System Diseases |
Periodontitis |
|
Hepatitis C |
|
Inflammatory Bowel Diseases |
|
Gastroesophageal reflux disease |
|
Liver Fibrosis |
|
Liver Diseases |
|
Colitis |
|
Esophagitis |
|
Hepatitis |
|
Non-alcoholic Fatty Liver Disease |
|
Endocrine System Diseases |
PCOS |
|
Diabetes Mellitus |
|
Ovarian Hyperstimulation Syndrome |
|
Immune System Diseases |
Rheumatoid Arthritis |
31520804, 27079198, 26164649, 26838552, 23897768, 24816316, 22903258, 19931339, 20470394, 23515858, 22100329, 22032299, 22562984, 25860297, 26233505 |
Sarcoidosis |
|
Juvenile arthritis |
|
Lymphoproliferative Disorder |
|
HIV Infections |
|
Allergic rhinitis |
|
AIDS |
|
Granulomatous Disease |
|
Musculoskeletal Diseases |
Osteogenesis Imperfecta |
|
Osteoarthritis |
|
Arthritis |
|
Neoplasms |
Ovarian Cancer |
|
Multiple Sclerosis |
|
Colonic Neoplasms |
|
Lymphoma |
|
Pancreatic Neoplasm |
|
Squamous Cell Carcinoma |
30883339, 24390317, 27566562, 22108521, 23516093, 25950115, 20943850, 22782903, 24651474, 31138255, 28380431 |
Liver Cancer |
24595450, 27150195, 26776075, 26637228, 26935703, 24333181, 21229610, 27099435, 22213236, 23925649, 18555017, 25956842, 24804874, 22552153, 22105822, 25519019, 22174818, 25275448, 24227773 |
Breast Cancer |
|
Carcinoma |
|
Colorectal Cancer |
29701752, 26756616, 27916606, 26524859, 27135244, 24819398, 26848774, 28846828, 24841830, 29363233, 20413677, 22703586 |
Mesothelioma |
|
Esophagus Neoplasm |
|
Multiple Myeloma |
|
Myeloid Leukemia |
|
Leukemia |
30515779, 24727676, 16325577, 30878131, 29068867, 24479800, 25388103, 25833959, 19017354, 22209839, 19144983, 26499078, 20418243, 22967415, 23286334, 23484694, 21408091, 19717645, 17260024, 22456238, 19148136, 25060657, 20561445, 23152777, 21926415, 20110180, 22912766 |
Gastric Cancer |
22860003, 25888377, 28641313, 25159729, 23806809, 25367852, 21628394, 24902858, 23898078, 19951901, 29317648 |
Hematopoietic Neoplasms |
|
Lung Cancer |
|
Osteosarcoma |
|
Endometrial Cancer |
|
Glioma |
|
Glioblastoma |
|
Nasopharyngeal Cancer |
|
Hematologic Neoplasms |
|
Sarcoma |
|
Glioblastoma Multiforme |
|
Polycythemia vera |
|
Rectal Neoplasms |
|
Hepatoblastoma |
|
Renal Cancer |
|
Fibroid Tumor |
|
Malignant Peripheral Nerve Sheath Tumor |
|
Vulvar Cancer |
|
Bladder Cancer |
|
Salivary Gland Neoplasms |
|
Prostate cancer |
|
Skin Cancer |
|
Nervous System Diseases |
Dementia |
|
Spinal Cord Diseases |
|
Demyelinating Diseases |
|
Cerebral Artery Infarction |
|
Transient Ischemic Attack |
|
Parkinson Disease |
|
Muscular Dystrophy |
|
Cerebral Thrombosis |
|
Systemic Lupus Erythematosus |
|
Cerebrovascular Disorders |
|
Brain Aneurysm |
|
Nutritional and Metabolic Diseases |
Metabolic Syndrome X |
|
Obesity |
|
Hypocalciuric hypercalcemia |
|
Metabolic Bone Disorder |
|
Hyperglycemia |
|
Hypercholesterolemia |
|
Hyperuricemia |
|
Psychiatric/Brain disorders |
Pain Disorder |
|
Mental Depression |
|
Autistic Disorder |
|
Renal Disorder |
Kidney Tubular Necrosis |
|
Ascites |
|
Polycystic Kidney Diseases |
|
Reproductive disorders |
Ectopic Pregnancy |
|
Gestational Diabetes |
|
Preeclampsia |
|
Respiratory Tract Diseases |
Chronic Lung Injury |
|
Chronic Obstructive Pulmonary Disease |
|
Pulmonary Tuberculosis |
|
Pulmonary Fibrosis |
|
Asthma |
|
Pneumonia |
|
Skin and Connective Tissue Diseases |
Psoriasis |
|
Dermatitis |
|
Dermatomyositis |
|
Bleeding Disorder |
|
Leishmaniasis |
|
|
References |
|
|
|
PubMed ID |
Associated gene/s |
Associated condition |
Genetic Mutation |
Diagnostic Criteria |
Association with PCOS |
Ethnicity |
Conclusion |
|
IRS,P13K,AKT, GLUT4, MIR93, MIR133, PTEN |
PCOS, insulin resistance, hyperinsulinemia, type 2 diabetes mellitus (T2DM), cardiovascular disease |
|
National Institute of Health (1990) criteiria |
Related
|
21 PCOS women and 20 control women |
Overexpression of miR-93 resulted in downregulation of GLUT4 gene expression in adipocytes through direct targeting of the GLUT4 3'UTR, while inhibition of miR-93 activity led to increased GLUT4 expression. These results point to a novel mechanism for regulating insulin-stimulated glucose uptake via miR-93 and demonstrate upregulated miR-93 expression in all PCOS, and in non-PCOS women with IR, possibly accounting for the IR of the syndrome. In contrast, miR-133 and miR-223 may have a different, although yet to be defined, role in the IR of PCOS. |
|
TNF-?, GLUT4 |
PCOS, insulin resistance, compensatory hyperinsulinemia, type 2 diabetes mellitus (T2DM), metabolic syndrome |
|
National Institute of Health (1990) criteiria |
Related
|
18 PCOS women and 15 control women |
miR-223 is an IR-related miRNA that may serve as a potential therapeutic target for the treatment of IR-related disorders. |
|
|
|
|